Alzheimer’s disease is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer’s treatment is a high risk, high reward market. Drugs currently available in the market have reached maturity; patent of leading drugs have expired. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies.
Check the Discount on this report @ http://www.orbisresearch.com/contacts/discount/175253 .
Global Alzheimer’s Disease Drugs Market and Pipeline Drugs Analysis: In 2014, the global market for Alzheimer’s disease drugs was dominated by Namenda and Exelon. Aricept and Memary stands at the third and fourth spot respectively in terms of Alzheimer’s disease drugs sales in 2014. Ebixa, Razadyne/Reminyl, Rivastach and Nootropil are the other popular drugs in the Alzheimer’s disease market. With the patent expiration of popular drugs the sales of the Alzheimer’s drugs has also declined. However, there are several pipeline drugs like Solanezumab, Gantenerumab, Crenezumab and Lu AE58054 among others which are likely to hit the market during the period 2017 – 2020.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/175253 .
Global Alzheimer’s Disease Country Wise Analysis: In the Alzheimer’s disease drugs market, the United States is the largest market. Japan is the second leading market for Alzheimer’s disease drugs market accounting for XXX% market share in 2014. China stands at the third spot in the global Alzheimer’s disease drugs market being followed by India with XXX% share in the same year. The EU5 countries together accounted for over XXX% share of the global Alzheimer’s disease drugs market in 2014.
iGATE RESEARCH report titled “Global Alzheimer’s Disease Drugs Market & Pipeline Drugs Market Analysis to 2020” is a 150 page report with 74 Figures and 10 Tables. This report analyses the Alzheimer’s Disease Drugs Market, Alzheimer’s Disease Pipeline Drugs Market and Clinical Trials Analysis, Alzheimer’s Disease – Country Wise Drugs Market, Country Wise Alzheimer’s Disease Prevalence, Major Deals in Alzheimer’s Disease Drugs Market Landscape, Funding in Alzheimer’s Disease Drugs Research, Driving Factors and Challenges for Alzheimer’s Disease Drugs Market.
Browse the complete report @ http://www.orbisresearch.com/reports/index/global-alzheimers-disease-drugs-market-and-pipeline-drugs-market-analysis-to-2020 .
The Alzheimer’s Disease Drugs Market has been analyzed from 7 View Points:
- Alzheimer’s Disease – Drugs Sales and Forecast
2. Alzheimer’s Disease – Pipeline Drugs Sales Forecast
3. Alzheimer’s Disease Drugs – Country Wise Market and Forecast
4. Alzheimer’s Disease – Country Wise Prevalence and Forecast
5. Alzheimer’s Disease – Pipeline Drugs Clinical Trials Analysis
6. Alzheimer’s Disease – Major Deals in Alzheimer’s Drugs Market
7. Alzheimer’s Disease – Funding in Alzheimer’s Disease Research
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: firstname.lastname@example.org